Plalelet-dependent arterial thrombosis triggers most heart attacks and
strokes. Because the coagulation protease thrombin is the most potent
activator of platelets', identification of the platelet receptors for
thrombin is critical for understanding thrombosis and haemostasis. Pr
otease-activated receptor-1 (PAR1) is important for activation of huma
n platelets by thrombin(2-6), but plays no apparent role in mouse plat
elet activation(7-9) PAR3 is a thrombin receptor that is expressed in
mouse megakaryocytes(10). Here we report that thrombin responses in pl
atelets from PAR3-deficient mice were markedly delayed and diminished
but not absent. We have also identified PAR4, a new thrombin-activated
receptor. PAR4 messenger RNA was detected in mouse megakaryocytes and
a PAR4-activating peptide caused secretion and aggregation of PARS-de
ficient mouse platelets. Thus PAR3 is necessary for normal thrombin re
sponses in mouse platelets, but a second PAR4-mediated mechanism for t
hrombin signalling exists. Studies with PAR-activating peptides sugges
t that PAR4 also functions in human platelets, which implies that an a
nalogous dual-receptor system also operates isl humans. The identifica
tion of a two-receptor system for platelet activation by thrombin has
important implications for the development of antithrombotic therapies
.